Literature DB >> 28646283

CD4 T Cells in IBD: Crossing the Line?

Elisa K Boden1, James D Lord2,3.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28646283     DOI: 10.1007/s10620-017-4655-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2.

Authors:  James D Lord; Karine Valliant-Saunders; Hejin Hahn; Richard C Thirlby; Steven F Ziegler
Journal:  Dig Dis Sci       Date:  2012-06-27       Impact factor: 3.199

2.  T-cell receptor sequencing reveals the clonal diversity and overlap of colonic effector and FOXP3+ T cells in ulcerative colitis.

Authors:  James Lord; Janice Chen; Richard C Thirlby; Anna M Sherwood; Christopher S Carlson
Journal:  Inflamm Bowel Dis       Date:  2015-01       Impact factor: 5.325

Review 3.  Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.

Authors:  Patrick R Burkett; Gerd Meyer zu Horste; Vijay K Kuchroo
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

4.  Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.

Authors:  Zaruhi Hovhannisyan; Jacquelyn Treatman; Dan R Littman; Lloyd Mayer
Journal:  Gastroenterology       Date:  2010-12-11       Impact factor: 22.682

5.  Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.

Authors:  Aito Ueno; Humberto Jijon; Ronald Chan; Kim Ford; Christina Hirota; Gilaad G Kaplan; Paul L Beck; Marietta Iacucci; Miriam Fort Gasia; Herman W Barkema; Remo Panaccione; Subrata Ghosh
Journal:  Inflamm Bowel Dis       Date:  2013-11       Impact factor: 5.325

6.  Course of inflammatory bowel disease in patients infected with human immunodeficiency virus.

Authors:  Nikos Viazis; John Vlachogiannakos; Ourania Georgiou; Miltiadis Rodias; Dimosthenis Georgiadis; Vassilios Papastamopoulos; Ioannis G Baraboutis; Dimitrios G Karamanolis; Athanasios Skoutelis
Journal:  Inflamm Bowel Dis       Date:  2010-03       Impact factor: 5.325

7.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.

Authors:  Andre Franke; Dermot P B McGovern; Jeffrey C Barrett; Kai Wang; Graham L Radford-Smith; Tariq Ahmad; Charlie W Lees; Tobias Balschun; James Lee; Rebecca Roberts; Carl A Anderson; Joshua C Bis; Suzanne Bumpstead; David Ellinghaus; Eleonora M Festen; Michel Georges; Todd Green; Talin Haritunians; Luke Jostins; Anna Latiano; Christopher G Mathew; Grant W Montgomery; Natalie J Prescott; Soumya Raychaudhuri; Jerome I Rotter; Philip Schumm; Yashoda Sharma; Lisa A Simms; Kent D Taylor; David Whiteman; Cisca Wijmenga; Robert N Baldassano; Murray Barclay; Theodore M Bayless; Stephan Brand; Carsten Büning; Albert Cohen; Jean-Frederick Colombel; Mario Cottone; Laura Stronati; Ted Denson; Martine De Vos; Renata D'Inca; Marla Dubinsky; Cathryn Edwards; Tim Florin; Denis Franchimont; Richard Gearry; Jürgen Glas; Andre Van Gossum; Stephen L Guthery; Jonas Halfvarson; Hein W Verspaget; Jean-Pierre Hugot; Amir Karban; Debby Laukens; Ian Lawrance; Marc Lemann; Arie Levine; Cecile Libioulle; Edouard Louis; Craig Mowat; William Newman; Julián Panés; Anne Phillips; Deborah D Proctor; Miguel Regueiro; Richard Russell; Paul Rutgeerts; Jeremy Sanderson; Miquel Sans; Frank Seibold; A Hillary Steinhart; Pieter C F Stokkers; Leif Torkvist; Gerd Kullak-Ublick; David Wilson; Thomas Walters; Stephan R Targan; Steven R Brant; John D Rioux; Mauro D'Amato; Rinse K Weersma; Subra Kugathasan; Anne M Griffiths; John C Mansfield; Severine Vermeire; Richard H Duerr; Mark S Silverberg; Jack Satsangi; Stefan Schreiber; Judy H Cho; Vito Annese; Hakon Hakonarson; Mark J Daly; Miles Parkes
Journal:  Nat Genet       Date:  2010-12       Impact factor: 38.330

  7 in total
  5 in total

Review 1.  The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses.

Authors:  Reyes Gamez-Belmonte; Lena Erkert; Stefan Wirtz; Christoph Becker
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

2.  Schistosoma japonicum peptide SJMHE1 inhibits acute and chronic colitis induced by dextran sulfate sodium in mice.

Authors:  Wenqi Shan; Wenzhe Zhang; Fei Xue; Yongbin Ma; Liyang Dong; Ting Wang; Yu Zheng; Dingqi Feng; Ming Chang; Guoyue Yuan; Xuefeng Wang
Journal:  Parasit Vectors       Date:  2021-09-06       Impact factor: 3.876

Review 3.  Elucidating the Role of Innate and Adaptive Immune Responses in the Pathogenesis of Canine Chronic Inflammatory Enteropathy-A Search for Potential Biomarkers.

Authors:  Daniela Siel; Caroll J Beltrán; Eduard Martínez; Macarena Pino; Nazla Vargas; Alexandra Salinas; Oliver Pérez; Ismael Pereira; Galia Ramírez-Toloza
Journal:  Animals (Basel)       Date:  2022-06-27       Impact factor: 3.231

4.  Cytochrome P450 1A1 is essential for the microbial metabolite, Urolithin A-mediated protection against colitis.

Authors:  Sweta Ghosh; Bhagavatula Moorthy; Bodduluri Haribabu; Venkatakrishna Rao Jala
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 5.  Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD.

Authors:  Irma Tindemans; Maria E Joosse; Janneke N Samsom
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.